aluates Reports

$ 0.0

Automative

Global Clinical Trial Imaging Market Research Report 2026

Published Date: 2026-02-13

Report Code: QYRE-Auto-28U8971

Global Clinical Trial Imaging Market Size Status and Forecast 2022

BUY CHAPTERS

Global Clinical Trial Imaging Market Research Report 2026

Code: QYRE-Auto-28U8971

Report

2026-02-13

Pages:122

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ICON

ERT

McLaren

Bioclinica

PAREXEL

BioTelemetry

ProScan Imaging

Imaging Endpoints

Radiant Sage

Micron

Intrinsic Imaging

Median Technologies

Cardiovascular Imaging Technologies

Banook Medical

Ixico

Tigermed

Runda Medical

Konica Minolta

Keosys

Clinical Trial Imaging Market Size

The global Clinical Trial Imaging market was valued at US$ 1673 million in 2025 and is anticipated to reach US$ 2657 million by 2032, at a CAGR of 6.9% from 2026 to 2032.

Clinical Trial Imaging Market

Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.

The core manufacturers of clinical trial imaging in the world include Clario, ICON, McLaren, Calyx and BioTelemetry. The top five companies hold about 60% of the shares. North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, each with a share of about 27%. In terms of product type, central imaging services are the largest market segment, with a share of about 70%. In terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of subjects are fully guaranteed and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of trial results.

Clinical trial imaging plays an important role in different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.

For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.

In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and evaluation of treatment effects. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.

With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.

The driving factors of the clinical trial imaging market mainly include the following:

Technological progress: innovation drives core growth

High-precision and multimodal imaging technology

Breakthroughs in technologies such as MRI, CT, and PET: High-resolution imaging technology (such as 3T MRI and ultra-low-dose CT) provides more accurate anatomical and functional information, which helps early diagnosis of diseases and efficacy evaluation.

Multimodal fusion: The fusion technology of CT and MRI, PET and CT, combined with anatomical and metabolic information, significantly improves diagnostic sensitivity, such as in tumor staging.

Artificial Intelligence and Automation

AI-assisted analysis: Deep learning algorithms can automatically detect lesions (such as lung nodules and breast calcifications), reduce human errors, and improve diagnostic efficiency.

Process Automation: AI optimizes scanning protocols and automatically generates reports, shortens clinical trial cycles, and reduces costs.

Portable and Real-time Imaging

Portable ultrasound equipment: Suitable for bedside examinations and remote areas, expanding the coverage of clinical trials.

Real-time imaging technology: such as ultrasound elastic imaging, dynamically monitors changes in tissue hardness, and provides instant feedback for diseases such as liver fibrosis.

Policy support: Create a favorable development environment

Improvement of regulatory framework

FDA, NMPA and other agencies: Ensure the safety and effectiveness of equipment through strict approval processes, such as requiring that Class III medical imaging equipment must pass clinical trials before registration.

International Standard Coordination: Promote imaging protocols and data standardization (such as DICOM format) and promote multi-center trial data sharing.

Funding and Incentives

Government research funding: For example, China's "14th Five-Year Plan" special support for medical imaging technology to accelerate technology transformation.

Tax incentives and subsidies: Encourage corporate R&D and innovation, such as providing financial subsidies for localization projects of high-end imaging equipment.

Growth in medical demand: changes in population and disease structure

Aging and chronic disease burden

High incidence of cancer and neurodegenerative diseases: The global incidence of cancer is rising, driving the demand for early screening and efficacy monitoring.

Demand for precision medicine: Individualized treatment relies on high-precision imaging (such as molecular imaging in tumor targeted therapy).

New drug development and clinical trial expansion

Innovative drug development boom: The number of new drugs under development has surged globally, and the demand for imaging in clinical trials has increased accordingly.

Rare diseases and real-world research: Imaging technology helps small sample size trials and long-term efficacy tracking.

The growth of the clinical trial imaging market is the result of technological innovation, policy dividends, demand upgrades and the evolution of the competitive landscape. In the future, with the deep integration of AI, multimodal imaging and cloud technology, the market will accelerate its development towards intelligence and precision. At the same time, the rise of local companies will reshape the global competitive landscape and inject new vitality into the industry.

This report delivers a comprehensive overview of the global Clinical Trial Imaging market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Clinical Trial Imaging. The Clinical Trial Imaging market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Clinical Trial Imaging market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Clinical Trial Imaging manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Clinical Trial Imaging Market Report

Report Metric	Details
Report Name	Clinical Trial Imaging Market
Accounted market size in 2025	US$ 1673 million
Forecasted market size in 2032	US$ 2657 million
CAGR	6.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	In-house Imaging Service Central Imaging Service
Segment by Application	Pharmaceutical Companies Biotechnology Companies Academic Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., Intrinsic Imaging, Median Technologies, Cardiovascular Imaging Technologies, Banook Medical, IXICO, Tigermed, Runda Medical, Konica Minolta, Keosys
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Clinical Trial Imaging companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Clinical Trial Imaging Market growing?

Ans: The Clinical Trial Imaging Market witnessing a CAGR of 6.9% during the forecast period 2026-2032.

What is the Clinical Trial Imaging Market size in 2032?

Ans: The Clinical Trial Imaging Market size in 2032 will be US$ 2657 million.

What is the market share of major companies in Clinical Trial Imaging Market?

Ans: The top five companies hold about 60% of the shares.

Who are the main players in the Clinical Trial Imaging Market report?

Ans: The main players in the Clinical Trial Imaging Market are ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., Intrinsic Imaging, Median Technologies, Cardiovascular Imaging Technologies, Banook Medical, IXICO, Tigermed, Runda Medical, Konica Minolta, Keosys

What are the Application segmentation covered in the Clinical Trial Imaging Market report?

Ans: The Applications covered in the Clinical Trial Imaging Market report are Pharmaceutical Companies, Biotechnology Companies, Academic Institutes, Others

What are the Type segmentation covered in the Clinical Trial Imaging Market report?

Ans: The Types covered in the Clinical Trial Imaging Market report are In-house Imaging Service, Central Imaging Service

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Clinical Trial Imaging Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 In-house Imaging Service

1.2.3 Central Imaging Service

1.3 Market by Application

1.3.1 Global Clinical Trial Imaging Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical Companies

1.3.3 Biotechnology Companies

1.3.4 Academic Institutes

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Clinical Trial Imaging Market Perspective (2021–2032)

2.2 Global Clinical Trial Imaging Growth Trends by Region

2.2.1 Global Clinical Trial Imaging Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Clinical Trial Imaging Historic Market Size by Region (2021–2026)

2.2.3 Clinical Trial Imaging Forecasted Market Size by Region (2027–2032)

2.3 Clinical Trial Imaging Market Dynamics

2.3.1 Clinical Trial Imaging Industry Trends

2.3.2 Clinical Trial Imaging Market Drivers

2.3.3 Clinical Trial Imaging Market Challenges

2.3.4 Clinical Trial Imaging Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Clinical Trial Imaging Players by Revenue

3.1.1 Global Top Clinical Trial Imaging Players by Revenue (2021–2026)

3.1.2 Global Clinical Trial Imaging Revenue Market Share by Players (2021–2026)

3.2 Global Top Clinical Trial Imaging Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Clinical Trial Imaging Revenue

3.4 Global Clinical Trial Imaging Market Concentration Ratio

3.4.1 Global Clinical Trial Imaging Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Imaging Revenue in 2025

3.5 Global Key Players of Clinical Trial Imaging Head Offices and Areas Served

3.6 Global Key Players of Clinical Trial Imaging, Products and Applications

3.7 Global Key Players of Clinical Trial Imaging, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Clinical Trial Imaging Breakdown Data by Type

4.1 Global Clinical Trial Imaging Historic Market Size by Type (2021–2026)

4.2 Global Clinical Trial Imaging Forecasted Market Size by Type (2027–2032)

5 Clinical Trial Imaging Breakdown Data by Application

5.1 Global Clinical Trial Imaging Historic Market Size by Application (2021–2026)

5.2 Global Clinical Trial Imaging Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Clinical Trial Imaging Market Size (2021–2032)

6.2 North America Clinical Trial Imaging Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Clinical Trial Imaging Market Size by Country (2021–2026)

6.4 North America Clinical Trial Imaging Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Clinical Trial Imaging Market Size (2021–2032)

7.2 Europe Clinical Trial Imaging Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Clinical Trial Imaging Market Size by Country (2021–2026)

7.4 Europe Clinical Trial Imaging Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Clinical Trial Imaging Market Size (2021–2032)

8.2 Asia-Pacific Clinical Trial Imaging Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Clinical Trial Imaging Market Size by Region (2021–2026)

8.4 Asia-Pacific Clinical Trial Imaging Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Clinical Trial Imaging Market Size (2021–2032)

9.2 Latin America Clinical Trial Imaging Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Clinical Trial Imaging Market Size by Country (2021–2026)

9.4 Latin America Clinical Trial Imaging Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Clinical Trial Imaging Market Size (2021–2032)

10.2 Middle East & Africa Clinical Trial Imaging Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Clinical Trial Imaging Market Size by Country (2021–2026)

10.4 Middle East & Africa Clinical Trial Imaging Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ICON

11.1.1 ICON Company Details

11.1.2 ICON Business Overview

11.1.3 ICON Clinical Trial Imaging Introduction

11.1.4 ICON Revenue in Clinical Trial Imaging Business (2021–2026)

11.1.5 ICON Recent Development

11.2 ERT

11.2.1 ERT Company Details

11.2.2 ERT Business Overview

11.2.3 ERT Clinical Trial Imaging Introduction

11.2.4 ERT Revenue in Clinical Trial Imaging Business (2021–2026)

11.2.5 ERT Recent Development

11.3 McLaren

11.3.1 McLaren Company Details

11.3.2 McLaren Business Overview

11.3.3 McLaren Clinical Trial Imaging Introduction

11.3.4 McLaren Revenue in Clinical Trial Imaging Business (2021–2026)

11.3.5 McLaren Recent Development

11.4 Bioclinica

11.4.1 Bioclinica Company Details

11.4.2 Bioclinica Business Overview

11.4.3 Bioclinica Clinical Trial Imaging Introduction

11.4.4 Bioclinica Revenue in Clinical Trial Imaging Business (2021–2026)

11.4.5 Bioclinica Recent Development

11.5 Parexel

11.5.1 Parexel Company Details

11.5.2 Parexel Business Overview

11.5.3 Parexel Clinical Trial Imaging Introduction

11.5.4 Parexel Revenue in Clinical Trial Imaging Business (2021–2026)

11.5.5 Parexel Recent Development

11.6 BioTelemetry

11.6.1 BioTelemetry Company Details

11.6.2 BioTelemetry Business Overview

11.6.3 BioTelemetry Clinical Trial Imaging Introduction

11.6.4 BioTelemetry Revenue in Clinical Trial Imaging Business (2021–2026)

11.6.5 BioTelemetry Recent Development

11.7 ProScan Imaging

11.7.1 ProScan Imaging Company Details

11.7.2 ProScan Imaging Business Overview

11.7.3 ProScan Imaging Clinical Trial Imaging Introduction

11.7.4 ProScan Imaging Revenue in Clinical Trial Imaging Business (2021–2026)

11.7.5 ProScan Imaging Recent Development

11.8 Imaging Endpoints

11.8.1 Imaging Endpoints Company Details

11.8.2 Imaging Endpoints Business Overview

11.8.3 Imaging Endpoints Clinical Trial Imaging Introduction

11.8.4 Imaging Endpoints Revenue in Clinical Trial Imaging Business (2021–2026)

11.8.5 Imaging Endpoints Recent Development

11.9 Radiant Sage

11.9.1 Radiant Sage Company Details

11.9.2 Radiant Sage Business Overview

11.9.3 Radiant Sage Clinical Trial Imaging Introduction

11.9.4 Radiant Sage Revenue in Clinical Trial Imaging Business (2021–2026)

11.9.5 Radiant Sage Recent Development

11.10 Micron, Inc.

11.10.1 Micron, Inc. Company Details

11.10.2 Micron, Inc. Business Overview

11.10.3 Micron, Inc. Clinical Trial Imaging Introduction

11.10.4 Micron, Inc. Revenue in Clinical Trial Imaging Business (2021–2026)

11.10.5 Micron, Inc. Recent Development

11.11 Intrinsic Imaging

11.11.1 Intrinsic Imaging Company Details

11.11.2 Intrinsic Imaging Business Overview

11.11.3 Intrinsic Imaging Clinical Trial Imaging Introduction

11.11.4 Intrinsic Imaging Revenue in Clinical Trial Imaging Business (2021–2026)

11.11.5 Intrinsic Imaging Recent Development

11.12 Median Technologies

11.12.1 Median Technologies Company Details

11.12.2 Median Technologies Business Overview

11.12.3 Median Technologies Clinical Trial Imaging Introduction

11.12.4 Median Technologies Revenue in Clinical Trial Imaging Business (2021–2026)

11.12.5 Median Technologies Recent Development

11.13 Cardiovascular Imaging Technologies

11.13.1 Cardiovascular Imaging Technologies Company Details

11.13.2 Cardiovascular Imaging Technologies Business Overview

11.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Introduction

11.13.4 Cardiovascular Imaging Technologies Revenue in Clinical Trial Imaging Business (2021–2026)

11.13.5 Cardiovascular Imaging Technologies Recent Development

11.14 Banook Medical

11.14.1 Banook Medical Company Details

11.14.2 Banook Medical Business Overview

11.14.3 Banook Medical Clinical Trial Imaging Introduction

11.14.4 Banook Medical Revenue in Clinical Trial Imaging Business (2021–2026)

11.14.5 Banook Medical Recent Development

11.15 IXICO

11.15.1 IXICO Company Details

11.15.2 IXICO Business Overview

11.15.3 IXICO Clinical Trial Imaging Introduction

11.15.4 IXICO Revenue in Clinical Trial Imaging Business (2021–2026)

11.15.5 IXICO Recent Development

11.16 Tigermed

11.16.1 Tigermed Company Details

11.16.2 Tigermed Business Overview

11.16.3 Tigermed Clinical Trial Imaging Introduction

11.16.4 Tigermed Revenue in Clinical Trial Imaging Business (2021–2026)

11.16.5 Tigermed Recent Development

11.17 Runda Medical

11.17.1 Runda Medical Company Details

11.17.2 Runda Medical Business Overview

11.17.3 Runda Medical Clinical Trial Imaging Introduction

11.17.4 Runda Medical Revenue in Clinical Trial Imaging Business (2021–2026)

11.17.5 Runda Medical Recent Development

11.18 Konica Minolta

11.18.1 Konica Minolta Company Details

11.18.2 Konica Minolta Business Overview

11.18.3 Konica Minolta Clinical Trial Imaging Introduction

11.18.4 Konica Minolta Revenue in Clinical Trial Imaging Business (2021–2026)

11.18.5 Konica Minolta Recent Development

11.19 Keosys

11.19.1 Keosys Company Details

11.19.2 Keosys Business Overview

11.19.3 Keosys Clinical Trial Imaging Introduction

11.19.4 Keosys Revenue in Clinical Trial Imaging Business (2021–2026)

11.19.5 Keosys Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

ICON

ERT

McLaren

Bioclinica

PAREXEL

BioTelemetry

ProScan Imaging

Imaging Endpoints

Radiant Sage

Micron

Intrinsic Imaging

Median Technologies

Cardiovascular Imaging Technologies

Banook Medical

Ixico

Tigermed

Runda Medical

Konica Minolta

Keosys

List of Tables

Table 1. Global Clinical Trial Imaging Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of In-house Imaging Service

Table 3. Key Players of Central Imaging Service

Table 4. Global Clinical Trial Imaging Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Clinical Trial Imaging Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Clinical Trial Imaging Market Size by Region (US$ Million), 2021–2026

Table 7. Global Clinical Trial Imaging Market Share by Region (2021–2026)

Table 8. Global Clinical Trial Imaging Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Clinical Trial Imaging Market Share by Region (2027–2032)

Table 10. Clinical Trial Imaging Market Trends

Table 11. Clinical Trial Imaging Market Drivers

Table 12. Clinical Trial Imaging Market Challenges

Table 13. Clinical Trial Imaging Market Restraints

Table 14. Global Clinical Trial Imaging Revenue by Players (US$ Million), 2021–2026

Table 15. Global Clinical Trial Imaging Market Share by Players (2021–2026)

Table 16. Global Top Clinical Trial Imaging Players by Tier (Tier 1, Tier 2, and Tier 3), based on Clinical Trial Imaging Revenue, 2025

Table 17. Ranking of Global Top Clinical Trial Imaging Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Clinical Trial Imaging Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Clinical Trial Imaging, Headquarters and Area Served

Table 20. Global Key Players of Clinical Trial Imaging, Products and Applications

Table 21. Global Key Players of Clinical Trial Imaging, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Clinical Trial Imaging Market Size by Type (US$ Million), 2021–2026

Table 24. Global Clinical Trial Imaging Revenue Market Share by Type (2021–2026)

Table 25. Global Clinical Trial Imaging Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Clinical Trial Imaging Revenue Market Share by Type (2027–2032)

Table 27. Global Clinical Trial Imaging Market Size by Application (US$ Million), 2021–2026

Table 28. Global Clinical Trial Imaging Revenue Market Share by Application (2021–2026)

Table 29. Global Clinical Trial Imaging Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Clinical Trial Imaging Revenue Market Share by Application (2027–2032)

Table 31. North America Clinical Trial Imaging Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Clinical Trial Imaging Market Size by Country (US$ Million), 2021–2026

Table 33. North America Clinical Trial Imaging Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Clinical Trial Imaging Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Clinical Trial Imaging Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Clinical Trial Imaging Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Clinical Trial Imaging Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Clinical Trial Imaging Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Clinical Trial Imaging Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Clinical Trial Imaging Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Clinical Trial Imaging Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Clinical Trial Imaging Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Clinical Trial Imaging Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Clinical Trial Imaging Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Clinical Trial Imaging Market Size by Country (US$ Million), 2027–2032

Table 46. ICON Company Details

Table 47. ICON Business Overview

Table 48. ICON Clinical Trial Imaging Product

Table 49. ICON Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 50. ICON Recent Development

Table 51. ERT Company Details

Table 52. ERT Business Overview

Table 53. ERT Clinical Trial Imaging Product

Table 54. ERT Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 55. ERT Recent Development

Table 56. McLaren Company Details

Table 57. McLaren Business Overview

Table 58. McLaren Clinical Trial Imaging Product

Table 59. McLaren Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 60. McLaren Recent Development

Table 61. Bioclinica Company Details

Table 62. Bioclinica Business Overview

Table 63. Bioclinica Clinical Trial Imaging Product

Table 64. Bioclinica Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 65. Bioclinica Recent Development

Table 66. Parexel Company Details

Table 67. Parexel Business Overview

Table 68. Parexel Clinical Trial Imaging Product

Table 69. Parexel Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 70. Parexel Recent Development

Table 71. BioTelemetry Company Details

Table 72. BioTelemetry Business Overview

Table 73. BioTelemetry Clinical Trial Imaging Product

Table 74. BioTelemetry Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 75. BioTelemetry Recent Development

Table 76. ProScan Imaging Company Details

Table 77. ProScan Imaging Business Overview

Table 78. ProScan Imaging Clinical Trial Imaging Product

Table 79. ProScan Imaging Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 80. ProScan Imaging Recent Development

Table 81. Imaging Endpoints Company Details

Table 82. Imaging Endpoints Business Overview

Table 83. Imaging Endpoints Clinical Trial Imaging Product

Table 84. Imaging Endpoints Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 85. Imaging Endpoints Recent Development

Table 86. Radiant Sage Company Details

Table 87. Radiant Sage Business Overview

Table 88. Radiant Sage Clinical Trial Imaging Product

Table 89. Radiant Sage Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 90. Radiant Sage Recent Development

Table 91. Micron, Inc. Company Details

Table 92. Micron, Inc. Business Overview

Table 93. Micron, Inc. Clinical Trial Imaging Product

Table 94. Micron, Inc. Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 95. Micron, Inc. Recent Development

Table 96. Intrinsic Imaging Company Details

Table 97. Intrinsic Imaging Business Overview

Table 98. Intrinsic Imaging Clinical Trial Imaging Product

Table 99. Intrinsic Imaging Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 100. Intrinsic Imaging Recent Development

Table 101. Median Technologies Company Details

Table 102. Median Technologies Business Overview

Table 103. Median Technologies Clinical Trial Imaging Product

Table 104. Median Technologies Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 105. Median Technologies Recent Development

Table 106. Cardiovascular Imaging Technologies Company Details

Table 107. Cardiovascular Imaging Technologies Business Overview

Table 108. Cardiovascular Imaging Technologies Clinical Trial Imaging Product

Table 109. Cardiovascular Imaging Technologies Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 110. Cardiovascular Imaging Technologies Recent Development

Table 111. Banook Medical Company Details

Table 112. Banook Medical Business Overview

Table 113. Banook Medical Clinical Trial Imaging Product

Table 114. Banook Medical Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 115. Banook Medical Recent Development

Table 116. IXICO Company Details

Table 117. IXICO Business Overview

Table 118. IXICO Clinical Trial Imaging Product

Table 119. IXICO Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 120. IXICO Recent Development

Table 121. Tigermed Company Details

Table 122. Tigermed Business Overview

Table 123. Tigermed Clinical Trial Imaging Product

Table 124. Tigermed Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 125. Tigermed Recent Development

Table 126. Runda Medical Company Details

Table 127. Runda Medical Business Overview

Table 128. Runda Medical Clinical Trial Imaging Product

Table 129. Runda Medical Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 130. Runda Medical Recent Development

Table 131. Konica Minolta Company Details

Table 132. Konica Minolta Business Overview

Table 133. Konica Minolta Clinical Trial Imaging Product

Table 134. Konica Minolta Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 135. Konica Minolta Recent Development

Table 136. Keosys Company Details

Table 137. Keosys Business Overview

Table 138. Keosys Clinical Trial Imaging Product

Table 139. Keosys Revenue in Clinical Trial Imaging Business (US$ Million), 2021–2026

Table 140. Keosys Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

Table 144. Authors List of This Report

List of Figures

Figure 1. Clinical Trial Imaging Picture

Figure 2. Global Clinical Trial Imaging Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Clinical Trial Imaging Market Share by Type: 2025 vs 2032

Figure 4. In-house Imaging Service Features

Figure 5. Central Imaging Service Features

Figure 6. Global Clinical Trial Imaging Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Clinical Trial Imaging Market Share by Application: 2025 vs 2032

Figure 8. Pharmaceutical Companies Case Studies

Figure 9. Biotechnology Companies Case Studies

Figure 10. Academic Institutes Case Studies

Figure 11. Others Case Studies

Figure 12. Clinical Trial Imaging Report Years Considered

Figure 13. Global Clinical Trial Imaging Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Clinical Trial Imaging Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Clinical Trial Imaging Market Share by Region: 2025 vs 2032

Figure 16. Global Clinical Trial Imaging Market Share by Players in 2025

Figure 17. Global Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Clinical Trial Imaging Revenue in 2025

Figure 19. North America Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Clinical Trial Imaging Market Share by Country (2021–2032)

Figure 21. United States Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Clinical Trial Imaging Market Share by Country (2021–2032)

Figure 25. Germany Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Clinical Trial Imaging Market Share by Region (2021–2032)

Figure 33. China Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Clinical Trial Imaging Market Share by Country (2021–2032)

Figure 41. Mexico Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Clinical Trial Imaging Market Share by Country (2021–2032)

Figure 45. Israel Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Clinical Trial Imaging Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. ICON Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 49. ERT Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 50. McLaren Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 51. Bioclinica Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 52. Parexel Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 53. BioTelemetry Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 54. ProScan Imaging Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 55. Imaging Endpoints Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 56. Radiant Sage Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 57. Micron, Inc. Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 58. Intrinsic Imaging Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 59. Median Technologies Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 60. Cardiovascular Imaging Technologies Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 61. Banook Medical Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 62. IXICO Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 63. Tigermed Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 64. Runda Medical Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 65. Konica Minolta Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 66. Keosys Revenue Growth Rate in Clinical Trial Imaging Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global AI Clinical Trial Imaging Market Research Report 2024

Clinical Trials Imaging Market

Global Clinical Trial Imaging Platform Market Research Report 2024

Clinical Trial Imaging Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diagnostic Imaging Clinical Trials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Trial Imaging System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Devices Clinical Trials Market Research Report 2025

Global Medical Imaging Market Insights Forecast to 2030

Global Medical X Ray Imaging Device Market Research Report 2024

Global Medical X Ray Imaging System Market Research Report 2024

Global Clinical Trial Services Market Insights Forecast to 2030

Global Pre Clinical Imaging System Market Research Report 2024

Global Preclinical Brain Imaging Market Research Report 2024

Adult Radiology Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global In Vivo Preclinical Imaging System Market Research Report 2024

Global Clinical Trial Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Adult Imaging Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Preclinical Imaging Market Research Report 2024

Global Adult Medical Imaging Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions